semaglutide and naion A recent Veterans Health Administration–based target trial emulation evaluated the incidence of nonarteritic anterior ischemic optic neuropathy ( NAION) among adults with type 2 diabetes initiating compared with those initiating an SGLT2 Recent Meta-Analysis Argues NAION Risk

The rulings followed investigations prompted by the ASAs Active Ad Monitoring system, an artificial intelligence (AI) tool used to identify potentially non-compliant digital advertising

SRS, spontaneous-reporting system

Diagnosis is made with a biopsy showing spindle cells with wavy nuclei resembling fibrosarcoma

DeNoble AE, Kuller JA, Rhee EJ

Weeks 2 to 4: First Measurable Shifts Noticeable energy improvement

One of these trials also assessed anxiety symptoms and found no effect of liraglutide compared with placebo over 26 weeks in 80 patients with comorbid T2DM and obesity who had previously undergone bariatric surgery 186